Equity Profile

ICLR

ICON Public Limited Company

Health CareLife Sciences Tools & Services$12.9B

May28Thu

Pre-Earnings Brief

UpcomingQ1-2026After Close5:00 PM EDT

Company Snapshot

ICON Public Limited Company (ICLR) operates in the health care sector, specifically within life sciences tools and services. The company plays a crucial role in supporting pharmaceutical and biotechnology companies with clinical development and commercialization, which is increasingly important as the demand for innovative therapies grows.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well ICON is managing its costs and revenue.

$2.43

Revenue

Revenue figures will provide insight into the company's growth and market demand for its services.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

In Q4-2025, ICON reported an EPS of $2.52, slightly above expectations, and the stock rose by 4.04% the following day. The company has shown a consistent ability to exceed earnings expectations in recent quarters.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are generally optimistic about ICON's upcoming earnings, expecting it to meet or slightly exceed EPS and revenue estimates. The company's strong historical performance suggests a favorable outlook.

Bull Case

If ICON can deliver an EPS above $2.55 and show strong revenue growth, it may indicate robust demand for its services, driving the stock higher.

Bear Case

Conversely, if the company reports an EPS below $2.29 or shows stagnant revenue growth, it could raise concerns about its market position and lead to a decline in stock price.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of profitability and will show how well ICON is managing its costs and revenue.

Revenue

$2.0B

Revenue figures will provide insight into the company's growth and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will ICON's EPS exceed $2.55, indicating strong profitability?

A higher EPS would reinforce confidence in the company's financial health and growth prospects.

How does revenue compare to the $2.0B consensus?

Revenue performance is critical for assessing demand for ICON's services and overall market conditions.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for ICON to exceed revenue expectations due to recent trends in clinical development demand.

Supporting Evidence

ICON has consistently beaten EPS estimates in recent quarters, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting traders expect significant news.

The company's strong track record of revenue growth may not be fully reflected in current estimates.

Key Risk

If revenue comes in below $2.0B, it could undermine confidence in ICON's growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether ICON can maintain its strong earnings trajectory amid market challenges.

Bull Confirmed If

An EPS of $2.55 or higher would confirm strong profitability and growth.

Bear Confirmed If

An EPS below $2.29 would signal potential weakness in demand and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.66%

Pricing rich

The options market is pricing in a moderate move around the earnings report, suggesting that traders expect some volatility.

Options are pricing a larger move than the stock has historically averaged, indicating heightened expectations.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a potential stock increase of around +1.22%, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about -0.96%, reflecting concerns about the company's growth outlook.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive future revenue.
2Insights into market demand for clinical development services.
3Management's outlook on the competitive landscape in the life sciences sector.
4Details on cost management strategies and their impact on margins.
5Any commentary on potential challenges or headwinds in the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

JOYY Inc.

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well ICON is managing its costs and revenue.

$2.43

Revenue

Revenue figures will provide insight into the company's growth and market demand for its services.

$2.0B

Wall Street expectations, options signals, track record, and call prep available with Pro.

ICLR Q1-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+3.12%

Avg Stock Reaction

+1.30%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If ICON can deliver an EPS above $2.55 and show strong revenue growth, it may indicate robust demand for its services, driving the stock higher.

Bear Case

Conversely, if the company reports an EPS below $2.29 or shows stagnant revenue growth, it could raise concerns about its market position and lead to a decline in stock price.

Key Metrics to Watch

EPS

$2.43

Earnings per share is a key indicator of profitability and will show how well ICON is managing its costs and revenue.

Revenue

$2.0B

Revenue figures will provide insight into the company's growth and market demand for its services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will ICON's EPS exceed $2.55, indicating strong profitability?

A higher EPS would reinforce confidence in the company's financial health and growth prospects.

How does revenue compare to the $2.0B consensus?

Revenue performance is critical for assessing demand for ICON's services and overall market conditions.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for ICON to exceed revenue expectations due to recent trends in clinical development demand.

Supporting Evidence

ICON has consistently beaten EPS estimates in recent quarters, indicating strong operational performance.

The options market is pricing a larger move than historical averages, suggesting traders expect significant news.

The company's strong track record of revenue growth may not be fully reflected in current estimates.

Key Risk

If revenue comes in below $2.0B, it could undermine confidence in ICON's growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether ICON can maintain its strong earnings trajectory amid market challenges.

Bull Confirmed If

An EPS of $2.55 or higher would confirm strong profitability and growth.

Bear Confirmed If

An EPS below $2.29 would signal potential weakness in demand and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±2.09%

Historical Avg

±1.66%

Pricing rich

The options market is pricing in a moderate move around the earnings report, suggesting that traders expect some volatility.

Options are pricing a larger move than the stock has historically averaged, indicating heightened expectations.

Detail

ATM IV

0.6%

30d HV

74.0%

Calls (174K)P/C Ratio: 0.19Puts (149K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICON beats expectations, history suggests a potential stock increase of around +1.22%, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about -0.96%, reflecting concerns about the company's growth outlook.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive future revenue.
2Insights into market demand for clinical development services.
3Management's outlook on the competitive landscape in the life sciences sector.
4Details on cost management strategies and their impact on margins.
5Any commentary on potential challenges or headwinds in the upcoming quarters.